Related references
Note: Only part of the references are listed.Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study)
Jeffrey I. Zwicker et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Microparticle-associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological features
Johannes Thaler et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2013)
International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
D. Farge et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron
David H. Henry et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Novel High-Sensitive D-Dimer Determination Predicts Chemotherapy-Associated Venous Thromboembolism in Intermediate Risk Lung Cancer Patients
Patrizia Ferroni et al.
CLINICAL LUNG CANCER (2012)
High D-dimer levels are associated with poor prognosis in cancer patients
Cihan Ay et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Clinical significance of circulating microparticles for venous thromboembolism in cancer patients
J. Thaler et al.
HAMOSTASEOLOGIE (2012)
Risk of venous thromboembolism and primary prophylaxis in cancer Should all patients receive thromboprophylaxis?
I. Pabinger et al.
HAMOSTASEOLOGIE (2012)
Doppler ultrasound and D-dimer Friend or foe?
C. Riopel et al.
HAMOSTASEOLOGIE (2012)
A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score
Melina Verso et al.
INTERNAL AND EMERGENCY MEDICINE (2012)
Tumor Grade Is Associated With Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis Study
Jonas Ahlbrecht et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)
A. Tosetto et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients
J. Thaler et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Venous thromboembolism in cancer patients - Risk scores and recent randomised controlled trials
Johannes Thaler et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Circulating procoagulant microparticles in cancer patients
Johannes Thaler et al.
ANNALS OF HEMATOLOGY (2011)
Microparticles, malignancy and thrombosis
Sharon Zahra et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
The inhibition of pancreatic cancer invasion-metastasis cascade in both cellular signal and blood coagulation cascade of tissue factor by its neutralisation antibody
Yohei Saito et al.
EUROPEAN JOURNAL OF CANCER (2011)
Prediction of Venous Thromboembolism in Patients With Cancer by Measuring Thrombin Generation: Results From the Vienna Cancer and Thrombosis Study
Cihan Ay et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Thrombosis risk and survival in cancer patients with elevated C-reactive protein
R. Kanz et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Soluble p-selectin, D-dimer, and high-sensitivity C-reactive protein after acute deep vein thrombosis of the lower limb
Thomas Gremmel et al.
JOURNAL OF VASCULAR SURGERY (2011)
Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma
Johannes J. A. Auwerda et al.
THROMBOSIS AND HAEMOSTASIS (2011)
The role of fibrinogen plasma levels, the-455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis
Vera Tiedje et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial
M. Mandala et al.
ANNALS OF ONCOLOGY (2010)
D-dimer level as a risk factor for postoperative venous thromboembolism in Japanese women with gynecologic cancer
J. Kodama et al.
ANNALS OF ONCOLOGY (2010)
Prediction of venous thromboembolism in cancer patients
Cihan Ay et al.
BLOOD (2010)
Risk Assessment of Recurrence in Patients With Unprovoked Deep Vein Thrombosis or Pulmonary Embolism The Vienna Prediction Model
Sabine Eichinger et al.
CIRCULATION (2010)
High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)
R. Simanek et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy
Gregory C. Connolly et al.
THROMBOSIS RESEARCH (2010)
Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism
David A. Manly et al.
THROMBOSIS RESEARCH (2010)
High Factor VIII Levels Independently Predict Venous Thromboembolism in Cancer Patients The Cancer and Thrombosis Study
R. Vormittag et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Biomarkers and Venous Thromboembolism
Ingrid Pabinger et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
C-reactive protein stimulates superoxide anion release and tissue factor activity in vivo
Sridevi Devaraj et al.
ATHEROSCLEROSIS (2009)
D-dimer before chemotherapy might predict venous thromboembolism
Guido Arpaia et al.
BLOOD COAGULATION & FIBRINOLYSIS (2009)
Tumor-Derived Tissue Factor-Bearing Microparticles Are Associated With Venous Thromboembolic Events in Malignancy
Jeffrey I. Zwicker et al.
CLINICAL CANCER RESEARCH (2009)
Preoperative Plasma D-Dimer Is a Predictor of Postoperative Deep Venous Thrombosis in Colorectal Cancer Patients: A Clinical, Prospective Cohort Study with One-Year Follow-Up
Mogens T. Stender et al.
DISEASES OF THE COLON & RECTUM (2009)
D-Dimer and Prothrombin Fragment 1+2 Predict Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis Study
Cihan Ay et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study
Giancarlo Agnelli et al.
LANCET ONCOLOGY (2009)
High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)
Cihan Ay et al.
BLOOD (2008)
Development and validation of a predictive model for chemotherapy-associated thrombosis
Alok A. Khorana et al.
BLOOD (2008)
Thrombin generation testing in routine clinical practice: are we there yet?
J. J. van Veen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Erythrocyte vesiculation:: a self-protective mechanism?
Frans L. A. Willekens et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation
M. Davila et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer
A. A. Khorana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
D-dimer and factor VIII are independent risk factors for recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis
Benilde Cosmi et al.
THROMBOSIS RESEARCH (2008)
Interaction of cancer cells with platelets mediated by Necl-5/poliovirus receptor enhances cancer cell metastasis to the lungs
K. Morimoto et al.
ONCOGENE (2008)
Inhibition of platelet function: Does it offer a chance of better cancer progression control?
Ewa Sierko et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2007)
High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variant
Cihan Ay et al.
CLINICAL CHEMISTRY (2007)
Cancer and thrombosis: from molecular mechanisms to clinical presentations
H. R. Buller et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Microparticle-associated tissue factor activity: a link between cancer and thrombosis?
M. E. T. Tesselaar et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Platelet microparticle membranes have 50-to 100-fold higher specific procoagulant activity than activated platelets
Elena I. Sinauridze et al.
THROMBOSIS AND HAEMOSTASIS (2007)
Prothrombotic coagulation abnormalities in patients with newly diagnosed multiple myeloma
Johannes J. A. Auwerda et al.
HAEMATOLOGICA (2007)
D-dimer testing to determine the duration of anticoagulation therapy
Gualtiero Palareti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis
M Chen et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2006)
Sources of tissue factor
B Osterud et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2006)
Risk factors for venous thromboembolic events in cancer patients
K Kröger et al.
ANNALS OF ONCOLOGY (2006)
Association between patterns of nucleotide variation across the three fibrinogen genes and plasma fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study
AP Reiner et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study
AA Khorana et al.
CANCER (2005)
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality - An individual participant meta-analysis
J Danesh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation
P Cirillo et al.
CARDIOVASCULAR RESEARCH (2005)
Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines
B Szotowski et al.
CIRCULATION RESEARCH (2005)
Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia
R Pawlinski et al.
BLOOD (2004)
Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score
NA Zakai et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
D-dimer levels and risk of recurrent venous thromboembolism
S Eichinger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Coagulation factors, inflammation markers, and venous thromboembolism: The longitudinal investigation of thromboembolism etiology (LITE)
AW Tsai et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity
F Sabatier et al.
BLOOD (2002)
Platelets and cancer: Implications for antiangiogenic therapy
M Trikha et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2002)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
High plasma levels of factor VIII and the risk of recurrent venous thromboembolism.
PA Kyrle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Release of active tissue factor by human arterial smooth muscle cells
AD Schecter et al.
CIRCULATION RESEARCH (2000)
Increased soluble P-selectin levels following deep venous thrombosis: cause or effect
AD Blann et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Share Paper
